Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Tan Sheet

Executive Summary

Okla. AG opposes local Rx-only PSE laws

You may also be interested in...



Tennessee AG Challenges Local PSE Prescription Laws

Tennessee AG Robert Cooper pushes back against local ordinances to require prescriptions for pseudoephedrine. Acura Pharmaceuticals says stricter local laws could block potential extraction-resistant products from OTC sale.

Tennessee AG Challenges Local PSE Prescription Laws

Tennessee AG Robert Cooper pushes back against local ordinances to require prescriptions for pseudoephedrine. Acura Pharmaceuticals says stricter local laws could block potential extraction-resistant products from OTC sale.

Regulatory News In Brief

FDA fires warning shot on Breathable Foods’ “inhalable caffeine”; agency guidance advises against phthalate excipients in drugs; pandemic adverse event reporting guidance finalized; Globe All Wellness recall of tainted supplements is insufficient; more Regulatory News In Brief.

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS105227

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel